Valley Forge Investment Consultants’s DataMeds AI MEDS Stock Holding History
Bought
Maintained
Sold
Other funds holding MEDS
TRCT
FFO
GRP
DB
Valley Forge Investment Consultants's MEDS Position: Q2 2026 in Review
Valley Forge Investment Consultants sold out of DataMeds AI (MEDS) in Q2 2026, closing a stake of 460 shares — an estimated $2.22K sold.
Valley Forge Investment Consultants first reported a position in MEDS in Q1 2025 and held it in 5 quarters. The position peaked at $99.3K in Q1 2025. 9 funds tracked by Wall St. Rank hold MEDS as of Q2 2026.
- Valley Forge Investment Consultants reported no remaining DataMeds AI position as of Q2 2026 after selling out during the quarter.
- Valley Forge Investment Consultants sold 460 DataMeds AI shares in Q2 2026, an estimated $2.22K.
- Valley Forge Investment Consultants first reported a position in DataMeds AI in Q1 2025 and held it in 5 quarters.
- Valley Forge Investment Consultants's DataMeds AI position peaked at $99.3K in Q1 2025.
- 9 funds tracked by Wall St. Rank held DataMeds AI as of Q2 2026.
Based on Valley Forge Investment Consultants's 13F filing for Q2 2026, filed 7 Aug 2026.